An in-depth look to Actuate Therapeutics, Inc. operating, investing, and financing activities

ACTU free cash flow for Q3 24 is -8.96 M USD. For 2023, ACTU free cash flow was -21.63 M USD and operating cash flow was -21.63 M USD.